![](/img/cover-not-exists.png)
Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)
Zinman, Bernard, Inzucchi, Silvio E, Lachin, John M, Wanner, Christoph, Ferrari, Roberto, Fitchett, David, Bluhmki, Erich, Hantel, Stefan, Kempthorne-Rawson, Joan, Newman, Jennifer, Johansen, Odd, WoeVolume:
13
Year:
2014
Language:
english
Journal:
Cardiovascular Diabetology
DOI:
10.1186/1475-2840-13-102
File:
PDF, 247 KB
english, 2014